These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
323 related items for PubMed ID: 15351967
1. PML nuclear bodies: dynamic sensors of DNA damage and cellular stress. Dellaire G, Bazett-Jones DP. Bioessays; 2004 Sep; 26(9):963-77. PubMed ID: 15351967 [Abstract] [Full Text] [Related]
2. Nuclear organization of PML bodies in leukaemic and multiple myeloma cells. Krejcí J, Harnicarová A, Kůrová J, Uhlírová R, Kozubek S, Legartová S, Hájek R, Bártová E. Leuk Res; 2008 Dec; 32(12):1866-77. PubMed ID: 18534676 [Abstract] [Full Text] [Related]
3. Role of nuclear bodies in apoptosis signalling. Krieghoff-Henning E, Hofmann TG. Biochim Biophys Acta; 2008 Nov; 1783(11):2185-94. PubMed ID: 18680765 [Abstract] [Full Text] [Related]
4. UV-C-induced DNA damage leads to p53-dependent nuclear trafficking of PML. Seker H, Rubbi C, Linke SP, Bowman ED, Garfield S, Hansen L, Borden KL, Milner J, Harris CC. Oncogene; 2003 Mar 20; 22(11):1620-8. PubMed ID: 12642865 [Abstract] [Full Text] [Related]
5. Nuclear bodies and compartments: functional roles and cellular signalling in health and disease. Zimber A, Nguyen QD, Gespach C. Cell Signal; 2004 Oct 20; 16(10):1085-104. PubMed ID: 15240004 [Abstract] [Full Text] [Related]
11. Functional proteomic analysis of promyelocytic leukaemia nuclear bodies in irradiation-induced MCF-7 cells. Liu J, Song Y, Tian B, Qian J, Dong Y, Liu J, Liu B, Sun Z. J Biochem; 2010 Dec 20; 148(6):659-67. PubMed ID: 20823370 [Abstract] [Full Text] [Related]
12. SUMO-dependent compartmentalization in promyelocytic leukemia protein nuclear bodies prevents the access of LRH-1 to chromatin. Chalkiadaki A, Talianidis I. Mol Cell Biol; 2005 Jun 20; 25(12):5095-105. PubMed ID: 15923626 [Abstract] [Full Text] [Related]
13. Activity-regulated cytoskeleton-associated protein Arc/Arg3.1 binds to spectrin and associates with nuclear promyelocytic leukemia (PML) bodies. Bloomer WA, VanDongen HM, VanDongen AM. Brain Res; 2007 Jun 11; 1153():20-33. PubMed ID: 17466953 [Abstract] [Full Text] [Related]
15. PODs in the nuclear spot: enigmas in the magician's pot. Hatta M, Fukamizu A. Sci STKE; 2001 Aug 21; 2001(96):pe1. PubMed ID: 11752673 [Abstract] [Full Text] [Related]
16. SAHA treatment overcomes the anti-apoptotic effects of Bcl-2 and is associated with the formation of mature PML nuclear bodies in human leukemic U937 cells. Lee JS, Jeong SH, Soung YH, Kim TH, Choi HJ, Park BS, Kwon TK, Yoo YH. Chem Biol Interact; 2009 Sep 14; 181(1):61-70. PubMed ID: 19631782 [Abstract] [Full Text] [Related]
17. [Post-translational Modifications of PML in Regulating the Functions of Nuclear Bodies --Review]. Ma XF, Tan Y, Li SF, Jin W, Wang KK. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Oct 14; 27(5):1696-1700. PubMed ID: 31607334 [Abstract] [Full Text] [Related]
18. Proteasome-dependent dispersal of PML nuclear bodies in response to alkylating DNA damage. Conlan LA, McNees CJ, Heierhorst J. Oncogene; 2004 Jan 08; 23(1):307-10. PubMed ID: 14712236 [Abstract] [Full Text] [Related]